Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one is an organic compound that serves as an intermediate in the synthesis of the pharmaceutical drug Sertraline. It is characterized by its brown solid appearance and plays a crucial role in the production of this medication.

124379-29-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 124379-29-9 Structure
  • Basic information

    1. Product Name: 4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one
    2. Synonyms: 4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-1(2H)-NAPHTALENE-1-ONE;4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE;4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-1(2H)-NAPHTHALENONE;4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-1(2H)-NAPHTHALENE-1-ONE;(4S)-(34Dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one;(S)-4-(3,4-Dichlorophenyl)-1-tetralon;(4S)-4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRONAPHTHALEN-1(2H)-ONE;4-(3,4-DICHLORO-PHENYL)-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE, 98+%
    3. CAS NO:124379-29-9
    4. Molecular Formula: C16H12Cl2O
    5. Molecular Weight: 291.17
    6. EINECS: 1592732-453-0
    7. Product Categories: Chiral Reagents;Miscellaneous Reagents
    8. Mol File: 124379-29-9.mol
  • Chemical Properties

    1. Melting Point: 840C
    2. Boiling Point: 403 °C at 760 mmHg
    3. Flash Point: 170.3 °C
    4. Appearance: brown solid
    5. Density: 1.318 g/cm3
    6. Vapor Pressure: 1.05E-06mmHg at 25°C
    7. Refractive Index: 1.618
    8. Storage Temp.: Refrigerator
    9. Solubility: Benzene (Slightly), Chloroform (Slightly), Dichloromethane, Methanol (Slightly)
    10. CAS DataBase Reference: 4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one(CAS DataBase Reference)
    11. NIST Chemistry Reference: 4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one(124379-29-9)
    12. EPA Substance Registry System: 4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one(124379-29-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 124379-29-9(Hazardous Substances Data)

124379-29-9 Usage

Uses

Used in Pharmaceutical Industry:
4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one is used as a key intermediate in the synthesis of Sertraline, a widely prescribed antidepressant medication. Its role in the production process is essential for creating the final drug product, which is utilized to treat various mental health conditions such as depression, anxiety, and obsessive-compulsive disorder.
As an intermediate in the synthesis of Sertraline, 4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one contributes to the development of an effective treatment option for individuals suffering from mood and anxiety disorders, highlighting its importance in the pharmaceutical industry.

Check Digit Verification of cas no

The CAS Registry Mumber 124379-29-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,4,3,7 and 9 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 124379-29:
(8*1)+(7*2)+(6*4)+(5*3)+(4*7)+(3*9)+(2*2)+(1*9)=129
129 % 10 = 9
So 124379-29-9 is a valid CAS Registry Number.
InChI:InChI=1/C16H12Cl2O/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11H,6,8H2

124379-29-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (4S)-(3',4'-Dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one

1.2 Other means of identification

Product number -
Other names 4-(3,4-Dichloro-phenyl)-3,4-dihydro-2H-naphthalen-1-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:124379-29-9 SDS

124379-29-9Relevant articles and documents

Asymmetric hydrogenation of a 4,4-diaryl-3-butenoate; a novel approach to sertraline.

Boulton, Lee T,Lennon, Ian C,McCague, Raymond

, p. 1094 - 1096 (2003)

The asymmetric hydrogenation of a selectively crystallised (E)-4,4-diaryl-3-butenoate with a rhodium-PhanePhos catalyst is described, providing an intermediate to the antidepressant sertraline.

A step-wise reduction of nonracemic α-ketoamides to α-methine amides under mild conditions

Wang, Bing,Wang, Min,Jia, Tao,Lou, Yazhou,Liao, Jian,Cao, Peng

, p. 2042 - 2047 (2016)

A step-wise reductive method that converts nonracemic γ-chiral α-ketoamides into amide derivatives was developed under mild conditions. The method involves a highly efficient three-step transformation including NaBH4-reduction, bromination and Pd/C hydrogenation reactions. As a consequence, a variety of nonracemic γ-diaryl amides products were obtained in high overall yields with excellent enantiomeric specificity. The utility of the method is demonstrated through the concise formal synthesis of (+)-sertraline in good overall yield.

Copper-Catalyzed Enantioselective Arylation via Radical-Mediated C-C Bond Cleavage: Synthesis of Chiral ω,ω-Diaryl Alkyl Nitriles

Cui, Guo-Qing,Dai, Jing-Cheng,Li, Yan,Li, Yuan-Bo,Hu, Duo-Duo,Bian, Kang-Jie,Sheng, Jie,Wang, Xi-Sheng

supporting information, p. 7503 - 7507 (2021/10/02)

The first example of copper-catalyzed ring-opening, enantioselective arylation of cyclic ketoxime esters to access ω,ω-diaryl alkyl nitriles has been developed in high yield (up to 92% yield) with excellent enantioselectivity (up to 91% ee). Side-arm bis(oxazoline) ligand plays a significant role in this asymmetric catalytic transformation, which provides an efficient route to construct diverse chiral ω,ω-diaryl alkyl nitriles. Synthetic utility has also been demonstrated in the further derivatization of the ω,ω-diaryl alkyl nitrile to the corresponding amide.

Exploring the synthetic potential of a marine transaminase including discrimination at a remote stereocentre

Schwarz, Maria,Murphy, Edel J.,Foley, Aoife M.,Woods, David F.,Castilla, Ignacio Abreu,Reen, F. Jerry,Collins, Stuart G.,O'gara, Fergal,Maguire, Anita R.

supporting information, p. 188 - 198 (2021/01/18)

The marine transaminase, P-ω-TA, can be employed for the transamination from 1-aminotetralins and 1-aminoindanes with differentiation of stereochemistry at both the site of reaction and at a remote stereocentre resulting in formation of ketone products with up to 93% ee. While 4-substituents are tolerated on the tetralin core, the presence of 3- or 8-substituents is not tolerated by the transaminase. In general P-ω-TA shows capacity for remote diastereoselectivity, although both the stereoselectivity and efficiency are dependent on the specific substrate structure. Optimum efficiency and selectivity are seen with 4-haloaryl-1-aminotetralins and 3-haloaryl-1-aminoindanes, which may be associated with the marine origin of this enzyme. This journal is

Chemoenzymatic Synthesis of Sertraline

Marx, Lisa,Ríos-Lombardía, Nicolás,Süss, Philipp,H?hne, Matthias,Morís, Francisco,González-Sabín, Javier,Berglund, Per

, p. 510 - 513 (2020/01/25)

A chemoenzymatic approach has been developed for the preparation of sertraline, an established anti-depressant drug. Ketoreductases (KREDs) were employed to yield a key chiral precursor. The bioreduction of the racemic tetralone exhibited excellent enantioselectivity (>99 % ee) and diastereomeric ratio (99:1) at 29 % conversion (the maximum theoretical yield is 50 %) after 7 hours. The resulting (S,S)-alcohol was efficiently oxidized to an enantiopure (S)-ketone, an immediate precursor of sertraline, by using sodium hypochlorite as oxidant and 2-azaadamantane N-oxyl (AZADO) as organocatalyst. Alternative routes aiming at the direct biocatalytic amination using imine reductases and transaminases were unsuccessful.

Identification of an Esterase Isolated Using Metagenomic Technology which Displays an Unusual Substrate Scope and its Characterisation as an Enantioselective Biocatalyst

Gavin, Declan P.,Murphy, Edel J.,Foley, Aoife M.,Castilla, Ignacio Abreu,Reen, F. Jerry,Woods, David F.,Collins, Stuart G.,O'Gara, Fergal,Maguire, Anita R.

, p. 2466 - 2474 (2019/03/11)

Evaluation of an esterase annotated as 26D isolated from a marine metagenomic library is described. Esterase 26D was found to have a unique substrate scope, including synthetic transformations which could not be readily effected in a synthetically useful manner using commercially available enzymes. Esterase 26D was more selective towards substrates which had larger, more sterically demanding substituents (i. e. iso-propyl or tert-butyl groups) on the β-carbon, which is in contrast to previously tested commercially available enzymes which displayed a preference for substrates with sterically less demanding substituents (e.g. methyl group) at the β-carbon. (Figure presented.).

Correction to: Nickel-catalyzed asymmetric reductive cross-coupling to access 1,1-diarylalkanes (Journal of the American Chemical Society (2017) 139 (5684-5687) DOI: 10.1021/jacs.7b01705)

Poremba, Kelsey E.,Kadunce, Nathaniel T.,Suzuki, Naoyuki,Cherney, Alan H.,Reisman, Sarah E.

supporting information, p. 7746 - 7746 (2018/06/26)

Pages 5684 and 5685, Table of Contents, and Supporting Information. The stereochemistry of L1, depicted as the (S,S)- enantiomer in Figure 1, Table 1, the TOC graphic (identical to Figure 1), and the Supporting Information of the original publication, was incorrect. (R,R)-L1 was used in this study. The stereochemistry of (R,R)-L1 has been confirmed by singlecrystal X-ray diffraction; the X-ray diffraction data and CIF file for (R,R)-L1 have been added to the Supporting Information. The corrected TOC graphic/Figure 1 is shown here. (R,R)-L4 and (R,R)-L5 were also used in Table 1 and incorrectly depicted as (S,S)-L4 and (S,S)-L5 in the original publication. To reflect that different enantiomeric series of catalysts were used, Table 1 has been updated to indicate that entries 2, 3, and 6 produce (S)-3a. This correction does not change the stereochemical assignment of the diarylalkane products, or the conclusions of the Communication. The stereochemistry of the products was assigned by obtaining an X-ray structure of diarylalkane 3k, and the rest of the compounds were assigned by analogy. (Table Presented).

Nickel-Catalyzed Asymmetric Reductive Cross-Coupling to Access 1,1-Diarylalkanes

Poremba, Kelsey E.,Kadunce, Nathaniel T.,Suzuki, Naoyuki,Cherney, Alan H.,Reisman, Sarah E.

supporting information, p. 5684 - 5687 (2017/05/04)

An asymmetric Ni-catalyzed reductive cross-coupling of (hetero)aryl iodides and benzylic chlorides has been developed to prepare enantioenriched 1,1-diarylalkanes. As part of these studies, a new chiral bioxazoline ligand, 4-heptyl-BiOX (L1), was developed in order to obtain products in synthetically useful yield and enantioselectivity. The reaction tolerates a variety of heterocyclic coupling partners, including pyridines, pyrimidines, indoles, and piperidines.

DIPHENYLOXIRANES, PROCESS FOR PREPARATION THEREOF, AND ITS USE IN AN ENANTIOSELECTIVE SYNTHESIS OF (+)-SERTRALINE

-

, (2016/06/28)

The present invention discloses substituted diphenyloxiranes and process for synthesis thereof. The present invention also provides a process for production of enantiomerically pure anti-3,3'-diphenylmethyloxirane and anti-3,3'-diphenylpropan- 1,2-diol from racemic anti-3,3'-diphenylmethyloxirane using hydrolytic kinetic resolution. Further it provides a process for preparation of enantioselective (+)- Sertraline from anti-3,3'-diphenylpropan-1,2-diol.

Rhodium-catalyzed asymmetric arylation of β,γ-unsaturated α-ketoamides for the construction of nonracemic γ,γ- diarylcarbonyl compounds

Wang, Juanjuan,Wang, Min,Cao, Peng,Jiang, Liyin,Chen, Guihua,Liao, Jian

supporting information, p. 6673 - 6677 (2014/07/08)

A highly regio- and enantioselective rhodium-catalyzed 1,4-addition of arylboronic acids to β,γ-unsaturated α-ketoamides using a simple new chiral sulfinylphosphine ligand is described. This transformation provides an attractive approach to construct chiral nonracemic γ,γ-diarylsubstituted carbonyl compounds, as exemplified in the concise syntheses of sertraline and tetrahydroquinoline-2-carboxylamide. Constructing chiral carbonyls: A simple new chiral sulfinylphosphine ligand L was developed, which promoted excellent 1,4-selectivities and enantioselectivities in the rhodium-catalyzed conjugate addition of arylboronic acids to β,γ-unsaturated α-ketoamides. The desired γ,γ-diaryl-α-ketocarbonyl compounds were afforded with high yields and high optical purities.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 124379-29-9